Details for New Drug Application (NDA): 071057
✉ Email this page to a colleague
NDA 071057 describes IBU-TAB 200, which is a drug marketed by Alra and is included in one NDA. Additional details are available on the IBU-TAB 200 profile page.
The generic ingredient in IBU-TAB 200 is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and forty suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
The generic ingredient in IBU-TAB 200 is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and forty suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 071057
| Tradename: | IBU-TAB 200 |
| Applicant: | Alra |
| Ingredient: | ibuprofen |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 071057
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
| Approval Date: | Aug 11, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
